A molecular architectural design that promises potent antimicrobial activity against multidrug-resistant pathogens
Source abstract
Abstract
Abstract Addressing the devastating threat of drug-resistant pathogens requires the discovery of new antibiotics with advanced action mechanisms and/or novel strategies for drug design. Herein, from a biophysical perspective, we design a class of synthetic antibacterial complexes with specialized architectures based on melittin (Mel), a natural antimicrobial peptide, and poly(ethylene glycol) (PEG), a clinically available agent, as building blocks that show potent and architecture-modulated antibacterial activity. Among the complexes, the flexibly linear complex consisting of one Mel terminally connected with a long-chained PEG (e.g., PEG12k–1*Mel) shows the most pronounced improvement in performance compared with pristine Mel, with up to 500% improvement in antimicrobial efficiency, excellent in vitro activity against multidrug-resistant pathogens (over a range of minimal inhibitory concentrations of 2–32 µg mL−1), a 68% decrease in in vitro cytotoxicity, and a 57% decrease in in vivo acute toxicity. A lipid-specific mode of action in membrane recognition and an accelerated “channel” effect in perforating the bacterial membrane of the complex are described. Our results introduce a new way to design highly efficient and low-toxicity antimicrobial drugs based on architectural modulations with clinically available agents.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Antimicrobial Peptides and Activities · Crystallography and molecular interactions · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Lewis, K. Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 12, 371–387 (2013).10.1038/nrd3975 ↗
2. Kuntz, I. D. Structure-based strategies for drug design and discovery. Science 257, 1078 (1992).10.1126/science.257.5073.1078 ↗
3. Rodrigues, T., Reker, D., Schneider, P. & Schneider, G. Counting on natural products for drug design. Nat. Chem. 8, 531–541 (2016).10.1038/nchem.2479 ↗
4. Sliwoski, G., Kothiwale, S., Meiler, J. & Lowe, E. W. Computational methods in drug discovery. Pharmacol. Rev. 66, 334 (2014).10.1124/pr.112.007336 ↗
5. López-Igual, R., Bernal-Bayard, J., Rodríguez-Patón, A., Ghigo, J.-M. & Mazel, D. Engineered toxin–intein antimicrobials can selectively target and kill antibiotic-resistant bacteria in mixed populations. Nat. Biotechnol. 37, 755–760 (2019).10.1038/s41587-019-0105-3 ↗
6. Schnaare, R. S. & Martin, A. N. Quantum chemistry in drug design. J. Pharm. Sci. 54, 1707–1713 (1965).10.1002/jps.2600541202 ↗
7. Luther, A. et al. Chimeric peptidomimetic antibiotics against Gram-negative bacteria. Nature 576, 452–458 (2019).10.1038/s41586-019-1665-6 ↗
8. Xing, R. et al. An injectable self‐assembling collagen–gold hybrid hydrogel for combinatorial antitumor photothermal/photodynamic therapy. Adv. Mater. 28, 3669–3676 (2016).10.1002/adma.201600284 ↗
9. Song, J. et al. Multifunctional antimicrobial biometallohydrogels based on amino acid coordinated self-assembly. Small 16, 1907309 (2020).10.1002/smll.201907309 ↗
10. Zhang, R. et al. Carrier-free, chemophotodynamic dual nanodrugs via self-assembly for synergistic antitumor therapy. ACS Appl. Mater. Interfaces 8, 13262–13269 (2016).10.1021/acsami.6b02416 ↗
11. Ma, K. et al. Injectable self-assembled dipeptide-based nanocarriers for tumor delivery and effective in vivo photodynamic therapy. ACS Appl. Mater. Interfaces 8, 30759–30767 (2016).10.1021/acsami.6b10754 ↗
12. Gelain, F., Luo, Z. & Zhang, S. Self-assembling peptide EAK16 and RADA16 nanofiber scaffold hydrogel. Chem. Rev. 120, 13434–13460 (2020).10.1021/acs.chemrev.0c00690 ↗
13. Yuan, B. et al. Self-assembly of highly oriented lamellar nanoparticle-phospholipid nanocomposites on solid surfaces. J. Am. Chem. Soc. 129, 11332–11333 (2007).10.1021/ja074235n ↗
14. Raghuraman, H. & Chattopadhyay, A. Melittin: a membrane-active peptide with diverse functions. Biosci. Rep. 27, 189–223 (2007).10.1007/s10540-006-9030-z ↗
15. Hong, W. et al. PEGylated self-assembled nano-Bacitracin A: probing the antibacterial mechanism and real-time tracing of target delivery in vivo. ACS Appl. Mater. Interfaces 10, 10688–10705 (2018).10.1021/acsami.8b00135 ↗
16. Lu, X. et al. Designing melittin-graphene hybrid complexes for enhanced antibacterial activity. Adv. Healthc. Mater. 8, 1801521 (2019).10.1002/adhm.201801521 ↗
17. Xiao, S. et al. Graphene oxide as antibacterial sensitizer: Mechanically disturbed cell membrane for enhanced poration efficiency of melittin. Carbon 149, 248–256 (2019).10.1016/j.carbon.2019.04.067 ↗
18. Marrink, S. J., Risselada, H. J., Yefimov, S., Tieleman, D. P. & de Vries, A. H. The MARTINI force field: coarse grained model for biomolecular simulations. J. Phys. Chem. B 111, 7812–7824 (2007).10.1021/jp071097f ↗
19. Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845–854 (2013).10.1093/bioinformatics/btt055 ↗
20. Balouiri, M., Sadiki, M. & Ibnsouda, S. K. Methods for in vitro evaluating antimicrobial activity: a review. J. Pharm. Anal. 6, 71–79 (2016).10.1016/j.jpha.2015.11.005 ↗
21. Zhang, X. et al. Quaternized silicon nanoparticles with polarity-sensitive fluorescence for selectively imaging and killing gram-positive bacteria. Adv. Funct. Mater. 26, 5958–5970 (2016).10.1002/adfm.201602185 ↗
22. Dou, Y. et al. Photo-voltage transients for real-time analysis of the interactions between molecules and membranes. ACS Appl. Bio Mater. 4, 620–629 (2021).10.1021/acsabm.0c01180 ↗
23. Gudheti, M. V., Mlodzianoski, M. & Hess, S. T. Imaging and shape analysis of GUVs as model plasma membranes: Effect of trans DOPC on membrane properties. Biophys. J. 93, 2011–2023 (2007).10.1529/biophysj.106.103374 ↗
24. L’Heureux, A. et al. Aminodifluorosulfinium salts: selective fluorination reagents with enhanced thermal stability and ease of handling. J. Org. Chem. 75, 3401–3411 (2010).10.1021/jo100504x ↗
25. Lu, N., Yang, K., Yuan, B. & Ma, Y. Molecular response and cooperative behavior during the interactions of melittin with a membrane: dissipative quartz crystal microbalance experiments and simulations. J. Phys. Chem. B 116, 9432–9438 (2012).10.1021/jp305141r ↗
26. Lee, M.-T., Sun, T.-L., Hung, W.-C. & Huang, H. W. Process of inducing pores in membranes by melittin. Proc. Natl. Acad. Sci. USA 110, 14243 (2013).10.1073/pnas.1307010110 ↗
27. Krauson, A. J., He, J. & Wimley, W. C. Gain-of-function analogues of the pore-forming peptide melittin selected by orthogonal high-throughput screening. J. Am. Chem. Soc. 134, 12732–12741 (2012).10.1021/ja3042004 ↗
28. Liu, J. et al. Molecular details on the intermediate states of melittin action on a cell membrane. Biochim. Biophys. Acta Biomembr. 1860, 2234–2241 (2018).10.1016/j.bbamem.2018.09.007 ↗
29. Deng, Z., Li, J., Yuan, B. & Yang, K. Residue-specialized membrane poration kinetics of melittin and its variants: Insight from mechanistic landscapes. Commun. Theor. Phys. 71, 887–902 (2019).10.1088/0253-6102/71/7/887 ↗
30. Hong, J. et al. How melittin inserts into cell membrane: conformational changes, inter-peptide cooperation, and disturbance on the membrane. Molecules 24, 1775 (2019).10.3390/molecules24091775 ↗
31. Sancho-Vaello, E. & Zeth, K. Antimicrobial peptides: has their time arrived? Future Microbiol. 10, 1103–1106 (2015).10.2217/fmb.15.45 ↗
32. Suk, J. S., Xu, Q., Kim, N., Hanes, J. & Ensign, L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 99, 28–51 (2016).10.1016/j.addr.2015.09.012 ↗
33. Guiotto, A. et al. PEGylation of the antimicrobial peptide nisin A: problems and perspectives. Il Farmaco 58, 45–50 (2003).10.1016/S0014-827X(02)01301-0 ↗
34. Veronese, F. M. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22, 405–417 (2001).10.1016/S0142-9612(00)00193-9 ↗
35. Gullapalli, R. P. & Mazzitelli, C. L. Polyethylene glycols in oral and parenteral formulations—A critical review. Int. J. Pharm. 496, 219–239 (2015).10.1016/j.ijpharm.2015.11.015 ↗
36. Imura, Y., Nishida, M., Ogawa, Y., Takakura, Y. & Matsuzaki, K. Action mechanism of tachyplesin I and effects of PEGylation. Biochim. Biophys. Acta Biomembr. 1768, 1160–1169 (2007).10.1016/j.bbamem.2007.01.005 ↗
37. Zhao, L., Liu, Y., Chang, R., Xing, R. & Yan, X. Supramolecular photothermal nanomaterials as an emerging paradigm toward precision cancer therapy. Adv. Funct. Mater. 29, 1806877 (2019).10.1002/adfm.201806877 ↗